跳至主要内容
临床试验/NCT00974714
NCT00974714已完成3 期

Effects of Oral L-arginine on Chronic Hypertension in Pregnancy

University of Modena and Reggio Emilia1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2007年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
to evaluate blood pressure changes during oral L-arginine or placebo administration in pregnant women with chronic hypertension at second trimester of gestation

研究概览

简要总结

The purpose of this study is to evaluate the effects of oral L-arginine administration on pregnant women at second trimester of gestation with chronic hypertension, respect with placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women between 18-20 weeks of gestation with chronic hypertension

排除标准

  • Other maternal or fetal systemic disease

研究组 & 干预措施

1

Experimental

Oral L-arginine 2 g twice a day, for 14 weeks

干预措施: L-arginine (Drug)

2

Placebo Comparator

oral placebo twice a day for 14 weeks

干预措施: placebo (Other)

结局指标

主要结局

to evaluate blood pressure changes during oral L-arginine or placebo administration in pregnant women with chronic hypertension at second trimester of gestation

时间窗: 14 weeks

次要结局

  • evaluate if is necessary to add a conventional therapy for hypertension, to evaluate pregnancy outcomes and eventual complications, to evaluate safety of oral L-arginine administration(14 weeks)

研究者

发起方
University of Modena and Reggio Emilia
申办方类型
Other

研究点 (1)

Loading locations...

相似试验